Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Alnylam Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- eHealth, Inc. Q3 2008 Earnings Call Transcript
- MIPS Technologies, Inc. F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Alexza Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- Alkermes, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Akorn, Inc. Q3 2008 Earnings Call Transcript
- Energy XXI (Bermuda) Limited F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
- The Advisory Board Company F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
- Thomas Weisel Partners Group, Inc. Q3 2008 Earnings Call Transcript
- The9 Q3 2008 Earnings Call Transcript
-
Editors' Picks
-
Most Popular
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Key to the Global Equity Market: Trend and Cycle Analysis of U.S. Retail
- Can a Global Economy Be Managed One Nation at a Time?
- Global Markets Week in Review: Turbulent Times
- Full list of Editors' Picks »
- Jim Rogers on China »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- Peak Oil's Bell Is Ringing »
- UltraShort ETFs: At a Tipping Point? »
- The Biggest Problem Detroit's Big Three Face »
- 11 Stocks Selling Below Cash »
- Tech May Be a Wreck, But This Isn't 2001 »
- The Autos and Mentality That Ruined Detroit »
- Iceland: What It's Like to Live in a World Without Money »
- Wall Street Breakfast: Must-Know News »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
mardez678
1 Comment
Isis-Genzyme: Deal of the Year?
When you invest in Biotech you must have a ten year, or more, time frame. This is about the time it takes for a drug to get to market - if at all.
ISIS is the first biotech drug I have ever invested in and I did so because of the science. It is innovative and looks at an aspect of our DNA/RNA makeup that reveals a potential to stop disease by stopping or turning off certain protein production functions specific to a certain disease and thereby preventing or stopping the disease.
Who else beleives that they can do this?
These companies: EI Lilly, Alnylam, Ortho-Mcneil, Bristol Myers Squibb, J & J, Pfizer, Achaogen, Merck & Co., Antisense Therapeutics, Atlantic, Healthcare(UK), iCO, ImQuest Pharmaceuticals, OncoGenex, Sarissa, Archemix, Ercole Biotec, Rosetta Genomics, Santaris Pharma, Idera Pharma, Integrated DNA Tech., Drug Royalty USA, Inc., Eyetech Pharma and finally there is IBIS, which manufactures the T5000, which can identify bacteria and virus in human clinical samples and give an antidote or a cure in a few hours. This last was essentially purchased by Abbott last month.
Should you own ISIS - only if you have patience and the willingness to stick with a formidable bio-tech company that has cutting edge technology to cure and prevent disease from opthalmic to cancer.
Disclosure: writer has common and call options on ISIS.